While the interaction with PAFR leads to NF-κB activation and consequently induction of COX and prostaglandins to a pro-inflammatory process and cell resistance37, a PPAR-γ agonist may induce prostate cancer growth inhibition39. The gene discussed is NFKB1; the disease is Familial prostate cancer.